Madrigal Pharmaceuticals Inc
MDGL
☕ $6/day into MDGL since 2015 would be worth $179,231 today — 10.4× the money.
Try your own number →Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Description from Yahoo Finance
Full profile on Yahoo Finance →If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of MDGL would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2007) — listing | $215,881 7.4× | $312,834 7.4× |
| Year 6 (2012) | $192,207 8.8× | $278,688 8.8× |
| Year 11 (2017) | $88,077 6.2× | $128,319 6.2× |
| Year 16 (2022) | $19,990 3.0× | $29,105 3.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with MDGL
For illustration only — not investment advice. Past performance is not indicative of future results.